BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19671824)

  • 21. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
    Wynn RL
    Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
    [No Abstract]   [Full Text] [Related]  

  • 22. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
    Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws.
    Pautke C; Bauer F; Tischer T; Kreutzer K; Weitz J; Kesting M; Hölzle F; Kolk A; Stürzenbaum SR; Wolff KD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):471-6. PubMed ID: 19231768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab.
    Yeo PM; Ang CC
    Ann Acad Med Singap; 2017 Aug; 46(8):329-330. PubMed ID: 28920136
    [No Abstract]   [Full Text] [Related]  

  • 26. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.
    Bedogni A; Blandamura S; Lokmic Z; Palumbo C; Ragazzo M; Ferrari F; Tregnaghi A; Pietrogrande F; Procopio O; Saia G; Ferretti M; Bedogni G; Chiarini L; Ferronato G; Ninfo V; Lo Russo L; Lo Muzio L; Nocini PF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):358-64. PubMed ID: 18280968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates--what the dentist needs to know: practical considerations.
    Fantasia JE
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):53-60. PubMed ID: 19371815
    [No Abstract]   [Full Text] [Related]  

  • 28. Bisphosphonate-associated osteonecrosis of the jaw.
    Basu N; Reid DM
    Menopause Int; 2007 Jun; 13(2):56-9. PubMed ID: 17540134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
    Omarini C; Filieri ME; Depenni R; Grizzi G; Cascinu S; Piacentini F
    Breast J; 2017 Sep; 23(5):610-611. PubMed ID: 28328105
    [No Abstract]   [Full Text] [Related]  

  • 30. A new class of drugs to prevent osteoporosis may be associated with osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2011; 59(1):10-2. PubMed ID: 21613033
    [No Abstract]   [Full Text] [Related]  

  • 31. Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.
    Pautke C; Otto S; Reu S; Kolk A; Ehrenfeld M; Stürzenbaum S; Wolff KD
    Oral Oncol; 2011 May; 47(5):425-9. PubMed ID: 21478047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates and the dental practitioner--a guide to management.
    Williamson R
    Ann R Australas Coll Dent Surg; 2010 Mar; 20():46-9. PubMed ID: 22046734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical image. Osteolytic jaw lesion in metastatic breast cancer: not always metastases. Osteonecrosis of the jaw.
    Alvarez-Busto I; Martinez-Moya L; Lastra R; Alcedo J; Quiles D; Lobo-Escolar A; Vazquez C; Burillo M; Toyas-Miazza C; Ortas-Nadal R
    N Z Med J; 2007 Sep; 120(1262):U2726. PubMed ID: 17891214
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 36. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 37. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study investigates novel approach to bone loss in the jaw.
    Garg A; Guez G
    Dent Implantol Update; 2011 Feb; 22(2):9-15. PubMed ID: 21425753
    [No Abstract]   [Full Text] [Related]  

  • 40. Fosamax and osteonecrosis of the jaw--important questions and answers.
    Wynn RL
    Gen Dent; 2008; 56(4):315-7. PubMed ID: 19284187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.